Inhibition of Mcl-1 by metformin was previously shown in AML cells (Zhou et al., 2021) and other tumors (Park et al., 2018; Ye et al., 2020; Chen et al., 2021). This evidence concerns the gene MCL1 and acute myeloid leukemia.